A new study indicates that men who suffer from obesity by the age of 20 are more likely to die, on average, eight years before their counterparts who are not obese.

Presented in Stockholm at the International Congress on Obesity, the research points towards the fact that obesity tends to develop before a person turns 20, and also that obesity is unlikely to develop later on.

The study was carried out amongst 5000 military conscripts ranging from the ages of 20 to 80 years. Around 2,000 of the participants were obese when the research began.

The results of the research indicate that premature death in obese men went up by 10% at every single point that exceeded the healthy level of 25 body mass index points. Figuring out a person’s body fat via a calculation which uses your weight and height is what is referred to as body mass index.

Esther Zimmermann of Copenhagen University Hospital who was the head of the study stated that at the age of 70, 70% of the males in the comparison group and 50% of them in the obese group were alive and well. Taking off from this, she said that they made an estimation that from the middle-aged years, obese men were more likely to die 8 years prior to their counterparts in the comparison group.

Zimmerman also said that other factors that were taken into consideration while carrying out the research were education, year of birth and smoking – however, hereditary diseases and other such factors were not.

An amazing network of cells, tissues and organs, the immune system is our body’s main defense against disease. However, there are many factors that affect the immune system and nutrition is one of them. This is why many of us do our best to take care of our bodies by eating right and taking an immune system booster such as ActivaMune.

ActivaMune, a patented dietary supplement, was created by a group of leading scientists in the fields of nutrition and molecular biology at the University of California at Berkeley. The ingredients include three main health-promoting nutrients that are naturally found in the Brassica vegetables: Diindolylmethane (DIM), Sulforaphane and Selenium.

The scientists at UC Berkeley have found that DIM is a strong activator of the immune system for both men and women, offering the body anticancer properties as well as antiviral and antibacterial properties. In addition, the scientists have demonstrated that DIM promotes Interferon-Gamma production and sensitivity in the body, which is another reason why it has strong immune enhancing properties. With many other health benefits including cellular detoxification and support for multiple organs, ActivaMune is an ideal immune system booster.

The use of medications to help suppress withdrawal symptoms and cravings in people struggling with addiction to heroin and other opiates has helped success rates in rehab.

There was a time when the common opinion within a rehab program was that a person needed to quit “cold turkey” in order to truly kick their drug addiction. The concept of using medication to help a person control their urges was not considered to be relevant, since many treatment doctors believed that this was merely replacing one drug for another and did not teach the patient how to live a drug-free life.

This idea was fallen by the wayside in recent years, as drug treatment concepts have advanced. Treatment specialists now release that a well-rounded treatment program can include the use of medication along with therapy and other treatment methods. Advances in treatment have made it easier for people to get effective treatment for their drug addiction and have a better chance of remaining free of drugs.

When it comes to heroin and other opioids, there are several different types of drugs which can be used in treatment received in an addiction center. Many different types of medication are used during the withdrawal process. Opiate addiction creates some of the most demanding withdrawal symptoms, and medication can help with both the physical and mental problems that arise during withdrawal. In the case of severe dependency on opiates, this withdrawal treatment can be done in a hospital setting with doctors and nurses who can treat patients in case significant side effects occur.

There are several types of drugs that are used in the treatment of heroin and opiate-derived prescription drug abuse. Drugs such as methadone and buprenorphine target the same sensory receptors that are excited during the use of heroin and morphine. These drugs help to relieve the cravings that addicts have along with suppressing withdrawal symptoms.

Another drug that is frequently used in the treatment of opioids in drug rehab centers is naltrexone. This is one of the more recent advancements in the medicinal treatment of heroin addiction. Naltrexone actually blocks the effects of heroin and other opioids at the brain’s receptor sites, limiting the amount of pleasure that a person receives from using it. However, naltrexone is not the best option if a person has not gone through detoxification in a drug rehab facility.

As parents who want nothing but the very best for their kids, watching a child suffer through alcohol or drug addiction might be one of your worst nightmares. We do our best to protect them from all the “bad things” that are waiting for them out there in the world, but sometimes it can seem almost impossible to keep up with just what lies on that list of bad things. Warning your son or daughter about the danger of booze and the reality of alcohol rehab might not convince them to avoid the hot new designer drug that just hit the streets.

Following the trends in teen drug use can be a difficult challenge, not only for parents, but for those who work in drug rehabs — the professionals tasked with helping our kids get clean. While it’s understandable that a brand new substance would catch the attention of teenagers looking to experiment, a sudden spike in the popularity of drugs that have been around for decades can be harder to fathom. While the pattern can be visible in rehab program patients, the underlying cause is sometimes very difficult to see.

There are organizations out there that are doing their best to track teen attitudes towards drugs and how they change, hopefully giving parents the insight that will help them keep their kids out of addiction treatment facilities. Monitoring the Future and Partnership for a Drug Free America have found that the perceptions of drugs vary widely among teenagers, and that there are noticeable variations between generations. These attitudes are one of the main influences on a drug’s popularity.

The “riskier” drugs seem to teenagers, whether the risk is real or perceived, the less likely teens are to use it. Risk includes physical, emotional, social, and aspiration. Kids don’t want to deal with legal trouble or drug-induced depression.

Conversely, if teens feel that using a certain drug is more acceptable, then the likelihood that they will experiment with it is higher. Availability plays a role as well, which explains why prescription drug and alcohol rehabs are in such high demand.

The pacemaker is one of the standard instruments used for treating heart patients. Likewise, monitoring the body’s signals can be done easily by implanting little devices inside the body. According to Jarno Riistama, a researcher from the Tampere University of Technology (TUT), such new measuring devices and applications hold great potential for the future tech-savvy generation.

The EKG or electrocardiogram which can be implanted into the body assists with monitoring your health. This is useful especially in emergencies as it gives paramedics and other medical officials an instant look at your EKG data.

This little instrument was developed by TUT in 2003 and thus has been utilized not just to monitor the health statistics of humans but also that of cattle. It is useful towards providing information regarding a bovine’s stress levels and also makes it easier to monitor how it responds to varied conditions.

Other participants in the research include the MTT Agrifood Research Finland and the University of Helsinki.

Riistama however states that while implantable devices such as the EKG exhibit positive results, it still needs more R&D. Meanwhile, he estimates that these devices will be out in the market in around ten year’s time. The decade long wait is attributed to a whole host of tests and approval procedures necessary to ensure that failure is impossible.

Apart from this implantable device, researchers at TUT have also developed one that monitors vital functions without having to be implanted, and instead works from the information it receives from the surface of the skin. This ultra-light device holds much potential not only for its size, but its production cost which is estimated at a mere few cents per piece.